Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2014 by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Sponsor:
Information provided by (Responsible Party):
William Crowley, Harvard University
ClinicalTrials.gov Identifier:
NCT00494169
First received: June 28, 2007
Last updated: May 29, 2014
Last verified: May 2014
  Purpose

The aims of this study are: 1) to identify genes that play a role in human pubertal development and reproduction, 2) to characterize the phenotypic spectrum of patients with these gene defects, and 3) to discern the mode of inheritance for disorders caused by these gene defects. We are specifically interested in genes that cause Kallmann syndrome, idiopathic hypogonadotropic hypogonadism (IHH), precocious (early) puberty, and delayed puberty. Individuals do not have to travel to Boston to participate in this study.


Condition
Hypogonadism
Kallmann Syndrome
Puberty, Delayed
Puberty, Precocious
Hypothalamic Amenorrhea
Anosmia
GnRH Deficiency

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional
Official Title: Molecular Basis of Inherited Reproductive Disorders

Resource links provided by NLM:


Further study details as provided by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD):

Primary Outcome Measures:
  • Identification of DNA abnormalities [ Time Frame: 5/2015 ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

WBC are transformed into immortalized cell lines.


Estimated Enrollment: 5000
Study Start Date: January 1999
Estimated Study Completion Date: May 2015
Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)
Detailed Description:

Overview:

Our work is divided into two main areas of investigation:

  1. the discovery of new, yet-undiscovered genes for conditions of early (i.e. precocious) puberty, delayed puberty, absence of pubertal development (i.e. Kallmann syndrome) as well as normal puberty that is accompanied by an altered reproductive system later in life (i.e. hypothalamic amenorrhea in women or very low testosterone levels in men). Identification of new genes requires either a single large family or a collection of smaller families.
  2. a detailed examination of the genes already implicated in causing these conditions.

There are several other important aspects about our program:

  • This analysis will detect DNA abnormalities only in those DNA segments being screened. The turnaround time to process a sample is approximately 6-9 months. We must receive a signed consent form in order to begin analysis on a blood sample.
  • Our laboratory is located in Massachusetts General Hospital, Boston MA and is largely funded by the National Institutes of Health. We are a research laboratory and not a CLIA certified clinical laboratory.
  • Even if a patient is the only member of his/her family affected by one of the conditions mentioned above, obtaining blood samples on other family members, including parents and siblings is often important to our work.
  • It is every individual's responsibility to notify the research team he/she would like to obtain research results. The patient must sign a second consent form before receiving such information.

Study Procedures and Risks

  • You will be asked to give approximately 3-5 tablespoons of blood for this research project. There is a risk of bruising and a very small amount of bleeding associated with blood drawing.
  • You will be asked to fill out a medical history checklist, indicating the presence or absence of clinical features that may be associated with abnormalities in pubertal development.
  • Since absence of puberty is sometimes associated with limited or no smell ability, you may be asked to try to identify the odors in a scratch and sniff test. This will take about 15 minutes.
  • Your family history can give us clues to determine how your condition was inherited. Therefore, a detailed family history, at least back to your grandparents will be obtained by a researcher.

Benefits:

There are no direct benefits to you from participation in this study. Some genes for this condition are known, other genes have yet to be discovered. If this study discovers what genes are responsible, it will help to further the understanding of this disorder. It is possible that the genetic cause of your reproductive disorder may be learned. This information can be shared with you at your request.

When contacting us, please include in your message a description of your diagnosis, your pubertal history (age when you hit pubertal hallmarks, e.g., growth spurt; body hair; voice deepening and genital growth for men; menstruation and breast development for women) and your reproductive history.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Subjects who

  1. fail to go through a normal, age-appropriate, spontaneous puberty, and abnormal hormone levels.
  2. have abnormally early development of puberty (Precocious Puberty) OR
  3. display low gonadotropins in adulthood after having gone through normal pubertal development.

Family members of these patients.

Criteria

Inclusion Criteria:

  • Failure to go through a normal, age-appropriate, spontaneous puberty, and abnormal hormone levels.
  • Children with abnormally early development of puberty (Precocious Puberty)
  • Adults who display low gonadotropins in adulthood after having gone through normal pubertal development.
  • Family members of these patients.

Exclusion Criteria:

  • pituitary tumor
  • high prolactin levels
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00494169

Contacts
Contact: Cassandra Buck, CGC, MS 617-726-5526 ReproEndoGenetics@partners.org
Contact: Nirav Patel, BA 617-726-1896 npatel34@partners.org

Locations
United States, Massachusetts
Massachusetts General Hospital Recruiting
Boston, Massachusetts, United States, 02114
Contact: Cassandra Buck, CGC, MS    617-726-5526    ReproEndoGenetics@partners.org   
Contact: Nirav Patel, BA    617-726-1896    npatel34@partners.org   
Sponsors and Collaborators
Investigators
Principal Investigator: William F Crowley, Jr., MD Massachusetts General Hospital
  More Information

Additional Information:
Publications:
Kallmann FJ, Schoenfeld WA. The genetic aspects of primary eunuchoidism. American Journal of Mental Deficiency 158:203-236, 1944.

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: William Crowley, Professor, Harvard University
ClinicalTrials.gov Identifier: NCT00494169     History of Changes
Other Study ID Numbers: U54HD028138
Study First Received: June 28, 2007
Last Updated: May 29, 2014
Health Authority: United States: Federal Government

Keywords provided by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD):
Idiopathic Hypogonadotropic Hypogonadism
Kallmann Syndrome
Puberty
Pituitary Abnormalities
Hypothalamus
anosmia
GnRH deficiency

Additional relevant MeSH terms:
Kallmann Syndrome
Amenorrhea
Olfaction Disorders
Hypogonadism
Puberty, Delayed
Puberty, Precocious
Menstruation Disturbances
Pathologic Processes
Sensation Disorders
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Gonadal Disorders
Endocrine System Diseases
46, XY Disorders of Sex Development
Disorders of Sex Development
Urogenital Abnormalities
Congenital Abnormalities
Genetic Diseases, Inborn

ClinicalTrials.gov processed this record on August 21, 2014